Top Pharmaceutical Companies in South Korea Clinical Trials

13:06 EDT 30th September 2016 | BioPortfolio

A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin

The purpose of this trial to compare the pharmacokinetic characteristics of YHD1119(Pregabalin 300mg) and Lyrica capsule(Pregabalin 150mg). YHD1119 is controlled release formulation which is made by Yuhan Corporation. Primary endpoints are Cmax,ss and AUCtau and secondary endpoints are AUClast,ss, AUCinf,ss, Tmax,ss and t1/2.

The Efficacy and Safety Study of Acupuncture for Polycystic Ovarian Syndrome

This study evaluates the efficacy and safety in improving ovarian function of polycystic ovarian syndrome in adults. Half of patients will receive Dong's extra-point acupuncture therapy, while the other half will receive Diane-35 as the control group.

Myocardial Regeneration and Angiogenesis in Myocardial Infarction With G-CSF and Intra-Coronary Stem Cell Infusion-3-DES

This trial was performed to evaluate the safety of G-CSF based stem cell therapy and to compare outcome of intracoronary infusion of mobilized PBSCs between patients with AMI and OMI.

Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient

Belotecan (Camtobell, CKD-602, Chong Kun Dang Pharm., Korea) is a new camptothecin derivative, that exhibits anticancer effects by inhibiting topoisomerase I. The investigators will have a randomized prospective multicenter trial of Belotecan/Cisplatin versus Etoposide/Cisplatin in patients with previously untreated, extensive-stage small cell lung cancer. Primary en...

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

The purpose of this study is to evaluate a scoring tool to help determine the presence of Heparin Induced Thrombocytopenia (HIT), which is an adverse reaction to heparin. We hypothesize that this scoring tool will be very useful in excluding patients who are suspected of having HIT.

An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds

- Investigational Device : TheraFill® (Atelocollagen Dermal Filler) - Title : A Randomized, Multicenter, Prospective and Paired Comparison of the Efficacy and Safety of TheraFill® versus KOKEN for 3months on Nasolabial Folds - Sites and investigators : - The Catholic University of Korea. Kangnam St. Mary's Hospital (#505, Banpo-dong, ...

Quick Search

review and buy Top Pharmaceutical Companies in South Korea market research data and corporate reports here